# Enteral Feeding Devices Market

> Global Enteral Feeding Devices Market Research Report: Size, Share, Trend Analysis By Device Type (Enteral Feeding Pumps, Enteral Feed Bags, Enteral Feeding Tubes, Accessories), By Applications (Oncology, Gastroenterology, Neurological Disorders, Critical Care), By End Users (Hospitals, Home Care Settings, Nursing Facilities, Ambulatory Surgical Centers), By Material (Plastic, Polymer, Silicone) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Competitor Industry Analysis and Trends Forecast Till 2035

- **Forecast Period:** 2026-2035
- **CAGR:** 6.15%
- **2025:** USD 3.96 Billion
- **2035:** USD 7.20 Billion
- **Key Players:** Abbott Laboratories, Danone (Nutricia), Fresenius Kabi, Nestlé Health Science, Cardinal Health, B. Braun Melsungen, Avanos Medical, Boston Scientific

**Report ID:** MRFR/HC/6357-HCR · **Pages:** 90 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** September 15, 2026

**URL:** https://www.marketresearchfuture.com/reports/enteral-feeding-devices-market-7828

---

## Market Summary

The Global Enteral Feeding Devices Market size was valued at USD 4.2 Billion in 2024, and the market is projected to grow from USD 4.4 Billion in 2025 to USD 7.006 Billion by 2035, registering a CAGR of 4.7% during the forecast period 2025–2035. North America led the market in 2024 with over 45% share, generating around USD 1.9 Billion in revenue.
 
Technological advancement in smart enteral feeding systems, coupled with rising chronic disease burden and demand for precision nutrition delivery, is accelerating market expansion by improving monitoring accuracy, reducing complications, and supporting long-term patient care in hospitals and home settings.
 
WHO highlights that noncommunicable diseases affect over 1.3 billion people globally, significantly increasing long-term clinical nutrition dependency. Rising chronic illness prevalence supports adoption of enteral feeding devices for sustained nutritional therapy and improved patient survival outcomes in critical care environments.

## Market Drivers

## Driver Impact Analysis

| Driver | ~% Impact on CAGR | Geographic Relevance | Impact Timeline | Ref |
| --- | --- | --- | --- | --- |
| Ageing population and dysphagia prevalence | ~1.35 | Global | Long-term (≥4 yr) | [3] |
| ENFit / ISO 80369-3 replacement cycle | ~1.10 | North America, Europe | Short-term (≤2 yr) | [5] |
| Shift of nutrition support to home settings | ~1.05 | North America, Europe, Japan | Medium-term (2–4 yr) | [4] |
| Oncology incidence and treatment-related malnutrition | ~0.90 | Global | Long-term (≥4 yr) | [7] |
| Smart pump connectivity and remote monitoring | ~0.75 | North America, Europe | Medium-term (2–4 yr) | [12] |
| Neonatal intensive care capacity build-out | ~0.65 | Asia-Pacific, MEA | Medium-term (2–4 yr) | [9] |
| Emerging-market hospital infrastructure spending | ~0.55 | Asia-Pacific, South America | Long-term (≥4 yr) | [17] |

### The ENFit Conversion Cycle

Legacy Luer-compatible designs were eliminated from the majority of acute-care supply chains through the GEDSA-coordinated implementation of ISO 80369-3 connectors. Beginning in January 2024, California's AB 1867 mandated ENFit-only enteral connections, and NHS Supply Chain framework awards now include compliance as a bid requirement [[5]](https://stayconnected.org)[[10]](https://supplychain.nhs.uk). Each mid-sized product line had conversion costs of USD 8–14 million, which put pressure on smaller suppliers and increased average selling prices by about 9%.

### Migration to Home Nutrition Support

Payers have taken decisive action. While Germany's Hilfsmittelverzeichnis and France's LPPR list both provide monthly device allowances for home enteral nutrition, US Medicare reimburses ambulatory pumps and supplies under HCPCS B9002 [[4]](https://medpac.gov)[[11]](https://ec.europa.eu). The Enteral Feeding Devices Market is increasingly selling to distributors and homecare agencies instead of hospital materials managers because home programs reduce per-patient episode costs by an estimated 62% compared to inpatient equivalents.

### Connected Pumps and Compliance Data

Second-generation ambulatory pumps now log delivered volume, occlusion events, and feed interruptions to clinician dashboards. Pilot deployments across 34 UK trusts reported an 18% reduction in unplanned readmissions tied to feeding intolerance [[10]](https://supplychain.nhs.uk)[[13]](https://danone.com). Connectivity also unlocks service revenue, a theme developed in.

## Restraints

## Restraints Impact Analysis

| Restraint | ~% Impact on CAGR | Geographic Relevance | Impact Timeline | Ref |
| --- | --- | --- | --- | --- |
| Tube-related complications and aspiration risk | ~-0.70 | Global | Long-term (≥4 yr) | [7] |
| Reimbursement caps and tender price erosion | ~-0.60 | Europe, Asia-Pacific | Medium-term (2–4 yr) | [11] |
| ENFit transition costs for small manufacturers | ~-0.45 | Global | Short-term (≤2 yr) | [5] |
| Shortage of trained nutrition support clinicians | ~-0.40 | Asia-Pacific, MEA, South America | Long-term (≥4 yr) | [9] |
| Preference for parenteral routes in complex cases | ~-0.30 | North America, Europe | Medium-term (2–4 yr) | [6] |

### Clinical Complication Risk

Although they are uncommon after ENFit, misconnection occurrences have serious consequences, and aspiration pneumonia affects 4–11% of long-term tube-fed patients [[7]](https://nutritioncare.org)[[15]](https://fda.gov). Clinicians are cautious about starting feeds because of litigation exposure and hospital quality measures, which prolong the sales cycle for novel device types.

### Pricing Pressure in Tendered Markets

Europe and most of Asia are dominated by centralized procurement. Italy's Drawbacks and the NHS Supply Chain. Since 2022, IP has used volume aggregation to bring administration-set costs down 11–16% [[10]](https://supplychain.nhs.uk)[[11]](https://ec.europa.eu). In response, manufacturers bundle pumps at little or no capital cost and recover margin on proprietary sets. This is a razor-and-blade strategy that German regulators have started to examine.

### Workforce and Training Gaps

Dietitian density in lower-middle-income countries averages under 2 per 100,000 population versus 27 in the United States [[3]](https://who.int)[[17]](https://worldbank.org). Without trained nutrition teams, hospitals default to syringe bolus feeding, deferring pump adoption regardless of device availability.

## Opportunities

## Enteral Feeding Devices Market Opportunities

### Low-Cost Pump Platforms for Emerging Markets

India's Ayushman Bharat scheme now covers 550 million beneficiaries, and tertiary hospital construction under PM-ABHIM adds ICU capacity in tier-2 cities [[9]](https://mohfw.gov.in). A sub-USD 400 pump with simplified set compatibility addresses a procurement band no incumbent currently serves, and would open the Enteral Feeding Devices Market to volumes that premium platforms cannot reach.

### Subscription and Data Monetisation Models

Feed-adherence data has commercial value to payers managing capitated home-care populations. Vendors piloting per-patient-per-month subscriptions that bundle device, sets, and dashboard access report gross margins 6–8 points above transactional sales [[12]](https://abbott.com)[[13]](https://danone.com). This reframes hardware as a customer-acquisition cost.

### Neonatal and Pediatric Specialisation

Pediatric feeding requires volumetric accuracy below 1 mL/hr and human-milk-compatible materials. Fewer than six manufacturers hold clearances across both, leaving a defensible niche as NICU beds expand across Asia-Pacific and the Gulf.

### Retail and Direct-to-Patient Channels

Online distribution captures only about one-fifth of current sales but grows at 7.55% CAGR. Pharmacy-led e-commerce in Japan and Brazil now fulfils repeat set orders with subscription refills, reducing patient supply interruptions [[16]](https://nestlehealthscience.com).

### Materials Innovation and Sustainability

Hospitals in the EU face single-use plastic reporting duties under the Green Deal procurement criteria. Polyurethane tube formulations with extended 8-week dwell times cut replacement frequency and waste volume by roughly 30% [[11]](https://ec.europa.eu)[[20]](https://eea.europa.eu).

## Future Outlook

## Enteral Feeding Devices Market Future Outlook

### Closed-Loop Feeding and Algorithmic Dosing

Pumps that adjust delivery rates against gastric residual sensing and continuous glucose data are in early clinical evaluation. If validated, closed-loop feeding would move the device from a timer to a therapy-management system, and command premium pricing in ICU settings where feed intolerance drives length of stay [[13]](https://danone.com).

### Platform Economics and Consumable Lock-In

Connector standardisation was meant to commoditise sets, yet manufacturers have re-differentiated through proprietary cassette geometries and software pairing. Expect regulatory attention: the EU Medical Device Regulation's interoperability provisions may compel open-set compatibility before 2030 [[11]](https://ec.europa.eu)[[20]](https://eea.europa.eu).

### Decentralised Care and the Hospital-at-Home Shift

CMS extended its Acute Hospital Care at Home waiver framework, and comparable schemes now operate in Australia, Spain, and Singapore. Roughly 40% of Enteral Feeding Devices Market revenue could originate outside hospital walls by 2035, versus about 29% today [[4]](https://medpac.gov)[[16]](https://nestlehealthscience.com).

### Sustainability and Circular Supply

Single-use polymer volumes draw scrutiny under EU reporting rules and NHS net-zero supplier roadmaps. Reprocessable pump housings and mono-material set designs are moving from pilot to tender requirement, and suppliers without lifecycle documentation will lose scoring points [[10]](https://supplychain.nhs.uk)[[20]](https://eea.europa.eu).

## Segment Insights

## Enteral Feeding Devices Market Segmentation

### By Product Type

| Segment | Metric (2025) | Primary Demand Driver |
| --- | --- | --- |
| Feeding Pumps (Volumetric and More) | 36.4% share | ICU accuracy requirements |
| Feeding Tubes (Nasogastric Tubes and More) | 7.10% CAGR | Routine replacement intervals |
| Giving / Administration Sets | USD 0.80 Billion | Daily single-use consumption |
| Enteral Syringes and Accessories | 10.0% share | ENFit-compliant bolus dosing |

Pumps anchor value in the Enteral Feeding Devices Market because they carry the software, service, and warranty layer that suppliers monetise. Tubes grow faster in volume: percutaneous gastrostomy placements rose an estimated 6% annually across OECD systems, and each patient consumes several devices per year [[8]](https://oecd.org)[[15]](https://fda.gov).

### By Age Group

| Segment | Metric (2025) | Primary Demand Driver |
| --- | --- | --- |
| Adults | 67.1% share | Stroke, oncology, neurological disease |
| Pediatric & Neonatal | 7.35% CAGR | NICU expansion, congenital conditions |

Adult caseloads dominate absolute demand, but neonatal units generate higher revenue per bed because low-flow accuracy commands specialised pumps and human-milk-compatible sets [[7]](https://nutritioncare.org).

### By Application

| Segment | Metric (2025) | Primary Demand Driver |
| --- | --- | --- |
| Oncology | 27.9% share | Treatment-related malnutrition |
| Gastroenterology | USD 0.85 Billion | Malabsorption and IBD management |
| Neurology | 18.2% share | Dysphagia after stroke |
| Critical Care & Trauma | 6.90% CAGR | Early feeding protocols |
| Diabetes | 8.3% share | Specialised formula delivery |
| Others | 7.4% share | Burns, surgical recovery |

Oncology dominates the market, accounting for a 27.9% share, driven by the high demand for specialized diagnostics, therapeutics, and supportive care across cancer treatment pathways. Critical Care & Trauma is the fastest-growing segment, projected to expand at a 6.90% CAGR, supported by increasing demand for advanced emergency care, critical-care technologies, and specialized treatment solutions. Gastroenterology generated USD 0.85 billion, while Neurology, Diabetes, and Others accounted for 18.2%, 8.3%, and 7.4% shares, respectively.

### By End-User and Distribution Channel

| Segment | Metric (2025) | Primary Demand Driver |
| --- | --- | --- |
| Hospitals | 49.7% share | Acute initiation of nutrition support |
| Home Care Settings | 6.70% CAGR | Payer cost-shifting |
| Long-Term Care Facilities | USD 0.52 Billion | Resident dysphagia prevalence |
| Ambulatory Care Centres | 8.5% share | Outpatient tube placement |
| Offline Channel | 79.6% share | Tender and distributor sales |
| Online Channel | 7.55% CAGR | Direct-to-patient refills |

Hospitals remain the clinical gateway, but the economics of the Enteral Feeding Devices Market now favour whoever controls the home resupply relationship. Long-term care sits between the two, buying on price with limited clinical differentiation [[4]](https://medpac.gov)[[16]](https://nestlehealthscience.com).

## Regional Market Share Analysis

## Regional Market Share Analysis

| Region | Metric (2025) | Primary Investment Themes |
| --- | --- | --- |
| North America | 33.9% share | ENFit enforcement, home infusion networks |
| Europe | 28.6% share | Malnutrition screening mandates, tender consolidation |
| Asia-Pacific | 6.95% CAGR (2026–2035) | NICU build-out, public insurance expansion |
| South America | USD 0.25 Billion | Private hospital growth, ANVISA harmonisation |
| Middle East & Africa | 4.8% share | Hospital megaprojects, oncology centre openings |
| Total | USD 3.96 Billion | — |

Geographic performance in the Enteral Feeding Devices Market divides between mature reimbursement systems replacing installed bases and emerging systems building capacity for the first time.

### North America

| Country | Metric | Key Driver |
| --- | --- | --- |
| US | 78.5% of regional revenue | Medicare Part B home enteral benefit |
| Canada | 5.85% CAGR | Provincial home-care nutrition programmes |
| Mexico | USD 0.12 Billion | IMSS hospital procurement modernisation |

US demand rests on an installed base of roughly 250,000 home-fed patients supported by durable medical equipment suppliers, with Medicare paying a monthly rental on ambulatory pumps [[4]](https://medpac.gov). Canada's provincial programmes fund supplies through regional health authorities, producing slower but highly predictable replacement cycles.

### Europe

| Country | Metric | Key Driver |
| --- | --- | --- |
| Germany | 21.8% of regional revenue | Hilfsmittelverzeichnis device funding |
| UK | 5.90% CAGR | NHS malnutrition screening via MUST |
| France | USD 0.17 Billion | LPPR reimbursement for home nutrition |
| Italy | 11.6% of regional revenue | Regional oncology network expansion |
| Spain | 8.7% of regional revenue | Long-term care capacity growth |
| Nordic Countries | 6.05% CAGR | Digital health integration pilots |
| Russia | USD 0.07 Billion | Domestic manufacturing substitution |
| Rest of Europe | 11.3% of regional revenue | Accession-state hospital upgrades |

European purchasing runs through consolidated frameworks that reward ENFit compliance and clinical evidence over price alone. ESPEN guideline revisions in 2024 formalised early enteral initiation within 48 hours for critically ill patients, lifting pump utilisation in ICUs across the bloc [[6]](https://espen.org)[[11]](https://ec.europa.eu).

### Asia-Pacific

| Country | Metric | Key Driver |
| --- | --- | --- |
| China | 30.2% of regional revenue | NMPA fast-track for domestic pumps |
| India | 7.60% CAGR | Ayushman Bharat tertiary care coverage |
| Japan | 21.4% of regional revenue | World's oldest population, dysphagia care |
| South Korea | USD 0.10 Billion | National Health Insurance device listing |
| ASEAN | 12.3% of regional revenue | Private hospital chain expansion |
| Rest of Asia-Pacific | 8.7% of regional revenue | Aid-funded NICU equipment programmes |

Japan anchors regional value while China and India supply the growth. Chinese volume-based procurement has compressed prices but expanded unit shipments sharply, and domestic manufacturers now hold a meaningful share in the pump category [[9]](https://mohfw.gov.in)[[19]](https://nmpa.gov.cn).

### South America

| Country | Metric | Key Driver |
| --- | --- | --- |
| Brazil | 54.3% of regional revenue | SUS oncology nutrition protocols |
| Argentina | 6.40% CAGR | PAMI coverage for elderly nutrition |
| Rest of South America | USD 0.06 Billion | Private insurer network growth |

Brazil's public system funds enteral nutrition through hospital-level budgets rather than a national device list, creating uneven adoption between states. ANVISA's 2024 alignment with ISO 80369-3 gives multinationals a registration pathway that domestic assemblers have struggled to match [[18]](https://gov.br/anvisa).

### Middle East & Africa

| Country | Metric | Key Driver |
| --- | --- | --- |
| Saudi Arabia | 27.4% of regional revenue | Vision 2030 hospital construction |
| UAE | 6.85% CAGR | Medical tourism and oncology centres |
| South Africa | 20.3% of regional revenue | Private hospital group standardisation |
| Egypt | USD 0.03 Billion | Universal health insurance rollout |
| Rest of MEA | 15.6% of regional revenue | Donor-funded neonatal programmes |

Gulf procurement favours premium connected platforms bundled with service contracts, while sub-Saharan demand concentrates in donor-financed neonatal units where simple gravity systems still dominate [[17]](https://worldbank.org).

## Competitive Benchmarking

## Competitive Benchmarking

Concentration is moderate. The top five suppliers hold an estimated 46–52% of global revenue, and the calculated HHI sits near 780 — below the threshold for a concentrated market but well above fragmentation. ENFit conversion costs have accelerated consolidation, with three regional set manufacturers acquired since 2023.

| Company | Est. Revenue Share Range | Key Offerings for Enteral Feeding Devices Market | Strategic Positioning |
| --- | --- | --- | --- |
| Abbott Laboratories | ~11–14% | Pumps, formula-device bundles, giving sets | Nutrition-plus-device integration |
| Danone (Nutricia) | ~9–12% | Pump platforms, pediatric feeding systems | Clinical nutrition franchise leverage |
| Fresenius Kabi | ~8–11% | Volumetric pumps, ENFit sets, tubes | Hospital tender specialist |
| Nestlé Health Science | ~7–10% | Ambulatory pumps, home-care kits | Home nutrition channel depth |
| Cardinal Health | ~6–9% | Tubes, syringes, distribution | Scale distribution and private label |
| Becton, Dickinson and Company | ~5–7% | Enteral syringes, safety connectors | Standards and safety leadership |
| B. Braun Melsungen | ~4–6% | Pumps, administration sets | European tender footprint |
| Avanos Medical | ~4–6% | Gastrostomy and jejunostomy systems | Interventional placement focus |
| Boston Scientific | ~3–5% | Percutaneous placement kits | Endoscopy channel adjacency |
| Cook Medical | ~2–4% | Low-profile buttons, access kits | Specialist procedural niche |
| ConvaTec Group | ~2–4% | Home-care tubes and accessories | Community care distribution |
| Moog Inc. (Curlin) | ~2–3% | Ambulatory infusion and feeding pumps | Portable device engineering |

## Recent News & Developments

## Recent News & Developments

- Abbott (March 2024): Launched an ENFit-native ambulatory pump with Bluetooth feed logging in the US, targeting home-care distributors [[12]](https://abbott.com).
- Fresenius Kabi (September 2024): Completed conversion of its entire European administration-set portfolio to ISO 80369-3, retiring legacy SKUs [[14]](https://fresenius.com).
- US FDA (January 2024): Issued updated labelling guidance for enteral misconnection prevention, tightening human-factors validation requirements [[15]](https://fda.gov).
- Danone Nutricia (June 2025): Partnered with a European telehealth provider to pair pump data with remote dietitian review across four countries [[13]](https://danone.com).
- Avanos Medical (November 2023): Acquired a low-profile gastrostomy button line, broadening its pediatric access portfolio [[12]](https://abbott.com).
- NHS Supply Chain (April 2025): Awarded a multi-year enteral consumables framework requiring lifecycle carbon disclosure from all bidders [[10]](https://supplychain.nhs.uk).
- NMPA China (February 2025): Added domestically manufactured feeding pumps to the centralised volume-based procurement list, compressing prices roughly 18% [[19]](https://nmpa.gov.cn).
- ANVISA Brazil (August 2024): Published harmonised connector requirements aligned to ISO 80369-3 with a 2026 compliance deadline [[18]](https://gov.br/anvisa).

## Report Scope

| Parameter | Detail |
| --- | --- |
| Market Scope | Global Enteral Feeding Devices Market — pumps, tubes, giving sets, syringes and accessories across hospital, home, long-term and ambulatory care |
| Study Period | 2021–2035 (Historical 2021–2024; Base Year 2025; Forecast 2026–2035) |
| CAGR | 6.15% (2026–2035) |
| Market Size Checkpoints | USD 3.96 Billion (2025); USD 4.21 Billion (2026); USD 7.20 Billion (2035) |
| Fastest Growing Segments | Feeding tubes (product), pediatric & neonatal (age group), online channel (distribution), critical care & trauma (application) |
| Companies Profiled | 12 profiled manufacturers including Abbott, Danone, Fresenius Kabi, Nestlé Health Science, Cardinal Health, BD, B. Braun, Avanos, Boston Scientific, Cook Medical, ConvaTec, Moog |
| Valuation Currency | USD Billion, constant 2025 exchange rates |

## Frequently Asked Questions

**Q: What procurement red flags should hospitals check before signing a pump supply contract in the Enteral Feeding Devices Market?**
A: Verify whether sets are proprietary and locked to the pump cassette. Contracts that bundle free hardware often recover cost through set pricing over five years. Request total-cost-of-ownership modelling before signing [10].

**Q: How do buyers evaluate ENFit compliance claims from smaller suppliers?**
A: Ask for third-party conformity test reports against ISO 80369-3, not self-declaration. Check that syringes, sets, and tubes were tested as a system rather than individually [2][5].

**Q: Which competitive threat is most underestimated in the Enteral Feeding Devices Market?**
A: Domestic Chinese pump manufacturers now win volume-based procurement tenders at price points multinationals cannot match. Their export push into ASEAN and Africa began in 2025 [19].

**Q: Are connected pumps worth the premium for community nursing teams?**
A: Yes, when caseloads exceed roughly 60 patients per nurse. Remote feed logging removes routine home visits and flags intolerance early, offsetting the hardware premium within two years [13].

**Q: What integration problems arise when adding feeding pumps to hospital IT systems?**
A: Most pumps export proprietary data formats rather than HL7 or FHIR. Budget for middleware and confirm EHR vendor certification before deployment [12].

**Q: How does reimbursement nuance affect vendor selection in the Enteral Feeding Devices Market?**
A: Coverage lists differ by country and often name specific device codes. A product without a national listing generates out-of-pocket exposure that clinicians will avoid prescribing [4][11].

**Q: Which emerging clinical use case will matter most by 2030?**
A: Post-bariatric and oncology outpatient nutrition support, delivered at home between treatment cycles. This cohort tolerates portable pumps and generates high consumable reorder frequency [7].


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/enteral-feeding-devices-market-7828*